Condition: Spinal Cord Injuries · Acute Traumatic Spinal Cord Injury · Sponsor: Francis Farhadi
This is a single-blinded (with outcome assessors blinded to treatment allocation), 12-month pilot study to evaluate of the safety, feasibility, and preliminary efficacy of dorsal myelotomy and expansive duraplasty performed either without or with autologous nerve graft implantation after acute traumatic spinal cord injury. Ten participants will be allocated to receive either DMED (n=5) or DMED + ANGI (n=5) based on a block design. Participants and assessors will be blinded to group allocation. Excess sural nerve samples will be collected for banking/analysis (may include proteomic, culturing, genomic, cellular analysis).
This description comes directly from the study's public registry record.
Francis H Farhadi, MD, PhD · 859-323-5661 · francis.farhadi@uky.edu
Harshit Arora, PhD · 859-323-4533 · harshit.arora@uky.edu
Always discuss trial participation with your own doctor first.
| University of Kentucky - Chandler Medical Center | Lexington, Kentucky, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06243211